An Investigational Study to Evaluate the Effects of Experimental Medication BMS-986256 in Healthy Participants

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: * Weight ≥ 50 kg and body mass index (BMI) between 18.0 and 32.0 kg/m2 inclusive at screening * Participants must not be current users (within 6 months before screening) of tobacco or tobacco- or nicotine-containing products; they must also be willing to refrain from using any of these products during their participation in the study * A negative QuantiFERON®-TB Gold test result at screening or documentation of a negative result within 3 months before screening Exclusion Criteria: * Previous participation in the current study or previous exposure within 6 weeks before study drug administration for non-biologics and 12 weeks before study drug administration for biologics * Inability to tolerate oral medication * Inability to tolerate venipuncture, or inadequate venous access Other protocol defined inclusion/exclusion criteria could apply